Rapida-acting insulin pen. (Products).
Novolog (insulin aspart, [rDNA origin] injection), a rapid-acting
insulin analogue, is now available in the FlexPen prefilled syringe for
treating diabetes. With faster absorption and onset, and a shorter
duration of action, the insulin analog is suited for mealtime bolus
dosing to control postprandial glycemia. The prefilled 3-mL pen can be
used for 28 days without refrigeration, and provides doses in one-unit
increments up to 60 units per injection (each pen contains 300 units).
For more information, contact Novo Nordisk Pharmaceuticals Inc.,